- Home
- PPIH vs GNLX Comparison
PPIH vs GNLX Comparison
Compare PPIH & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPIH
- GNLX
- Stock Information
- Founded
- PPIH 1993
- GNLX 2001
- Country
- PPIH United States
- GNLX United States
- Employees
- PPIH N/A
- GNLX N/A
- Industry
- PPIH Pollution Control Equipment
- GNLX Biotechnology: Pharmaceutical Preparations
- Sector
- PPIH Industrials
- GNLX Health Care
- Exchange
- PPIH Nasdaq
- GNLX Nasdaq
- Market Cap
- PPIH 67.7M
- GNLX 73.2M
- IPO Year
- PPIH N/A
- GNLX 2023
- Fundamental
- Price
- PPIH $11.94
- GNLX $2.78
- Analyst Decision
- PPIH
- GNLX Strong Buy
- Analyst Count
- PPIH 0
- GNLX 3
- Target Price
- PPIH N/A
- GNLX $22.33
- AVG Volume (30 Days)
- PPIH 37.9K
- GNLX 196.1K
- Earning Date
- PPIH 09-11-2024
- GNLX 11-12-2024
- Dividend Yield
- PPIH N/A
- GNLX N/A
- EPS Growth
- PPIH 215.46
- GNLX N/A
- EPS
- PPIH 1.90
- GNLX N/A
- Revenue
- PPIH $157,704,000.00
- GNLX $8,000.00
- Revenue This Year
- PPIH N/A
- GNLX N/A
- Revenue Next Year
- PPIH N/A
- GNLX N/A
- P/E Ratio
- PPIH $6.42
- GNLX N/A
- Revenue Growth
- PPIH 13.34
- GNLX N/A
- 52 Week Low
- PPIH $6.17
- GNLX $1.60
- 52 Week High
- PPIH $12.43
- GNLX $30.44
- Technical
- Relative Strength Index (RSI)
- PPIH 71.99
- GNLX 60.92
- Support Level
- PPIH $10.53
- GNLX $1.99
- Resistance Level
- PPIH $12.30
- GNLX $3.11
- Average True Range (ATR)
- PPIH 0.68
- GNLX 0.29
- MACD
- PPIH 0.19
- GNLX 0.05
- Stochastic Oscillator
- PPIH 95.38
- GNLX 62.16
About PPIH Perma-Pipe International Holdings Inc.
Perma-Pipe International Holdings Inc is engaged in the manufacture and sale of products in the reportable segment of Piping Systems. The company engineers, designs, manufactures and sells specialty piping systems and leak detection systems. Specialty piping systems include insulated and jacketed district heating and cooling piping systems for efficient energy distribution from central energy plants to multiple locations, primary and secondary containment piping systems for transporting chemicals, hazardous fluids and petroleum products, and the coating and insulation of oil and gas gathering and transmission pipelines. It operates in the United States, Canada, Middle East, Europe, India and other countries.
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.